How to Evaluate AI Mental Health Tools: Questions Every CHRO Should Ask Before Buying
- Jun 29
- 5 min read
In May 2023, the National Eating Disorders Association suspended its AI chatbot Tessa after it was documented recommending calorie deficits of up to 1,000 calories per day to people seeking help with eating disorders, according to NPR and CBS News. In February 2024, a 14-year-old boy died by suicide while messaging a Character.AI chatbot that had responded to his suicidal ideation with "come home to me," according to Psychiatric Times. By 2025, Brown University researchers had found a 32% rate of endorsing harmful behaviors toward teens across 137 LLM counseling sessions, according to JMIR Mental Health.
These were all consumer-grade AI products built without clinical oversight, and it is increasingly important for employers to ask whether the AI mental health tools being pitched to them share the same architectural gaps or whether they have been designed with clinical safety built in from the start. According to SHRM's 2026 State of AI in HR report, 92% of CHROs expect AI integration in their benefits to increase, while 56% do not formally measure whether the AI tools they have already deployed are working or safe.
Kyan Health is a modern EAP alternative and global mental health platform whose AI care companion, KAI, operates within defined clinical guardrails including real-time crisis detection, escalation to licensed professionals, and evidence-based content delivery.
This article draws from the Kyan Health AI Mental Health Vendor Scorecard, a free 30-question evaluation tool built on published clinical research, to outline what HR leaders should be asking before they buy.
Table of Content
Why Does AI in Mental Health Need a Different Evaluation Standard?
According to a preliminary report published in Psychiatric Times, AI chatbots fail to provide safe responses approximately 20% of the time, compared to a 7% failure rate among human therapists. The margin for error when an employee in distress reaches out at 1 a.m. is fundamentally different from a chatbot that misroutes a customer service request.
The academic world has produced more than 50 evaluation frameworks for AI in mental health, according to research published in Nature Digital Psychiatry and Neuroscience, but none were written for the HR leader running an RFP or the procurement team comparing vendors. The scorecard referenced in this article was built to close that gap.
What Are the Key Categories for Evaluating an AI Mental Health Vendor?
The Kyan Health AI Mental Health Vendor Scorecard organizes evaluation into seven categories informed by two published clinical frameworks: FAITA-Mental Health (Stanford, published in World Psychiatry 2024) and VERA-MH (open-source, built with Yale clinicians, 2025), alongside regulatory requirements from the EU AI Act, GDPR, HIPAA, PIPEDA, and California SB 243.
The seven categories are Clinical Safety and Crisis Protocols, Data Privacy and Regulatory Compliance, Transparency and Explainability, Evidence Base and Outcomes, Equity, Accessibility and Global Readiness, Vendor Governance and Accountability, and IT Security and Enterprise Integration. Each of the 30 questions is scored 0 to 3, for a maximum of 90 points.
What Should You Ask About Crisis Detection?
Clinical safety carries the most weight in the scorecard (18 out of 90 points) because the consequences of inadequate design are the most severe. Four questions matter most.
First, does the AI detect and escalate suicide risk, self-harm, and acute crisis in real time with validated risk detection, escalation to licensed clinicians, and a full audit trail, given that basic keyword flagging without clinical context is insufficient.
Second, has the crisis response been tested by clinicians independent of the vendor's own team.
Third, what happens when the AI encounters a scenario outside its scope, because the answer should be immediate transfer to a human professional with conversation context preserved.
Fourth, does the system run automated guardrails continuously rather than relying on periodic audits.
A score of zero on any question in this category should stop a procurement process regardless of how the vendor scores elsewhere.
What About Data Privacy for Global Employers?
For organizations operating across multiple jurisdictions, the regulatory landscape is complex and tightening. The EU AI Act classifies workplace AI systems as high-risk (compliance obligations take effect August 2026). GDPR classifies mental health data as special category data under Article 9. HIPAA governs any tool processing Protected Health Information in the US, and Canada's PIPEDA treats mental health data as among the most sensitive personal information.
One EU AI Act provision is particularly relevant: the prohibition on passive emotion recognition in employment contexts. According to analysis by Wolters Kluwer and the Center for Democracy & Technology, using AI to infer an employee's mood from behavioral, vocal, or biometric signals is strictly forbidden, with a narrow exception for fatigue monitoring in safety-critical roles. This is distinct from voluntary mood check-ins within a clinical care context, and any vendor relying on passive emotional inference without documented consent carries disqualifying regulatory risk for EU employers.
Kyan Health is HIPAA-compliant, GDPR-compliant, aligned with the EU AI Act, and operates across 200+ countries with EU data residency. KAI uses voluntary self-reported assessments within a clinical care context, with no passive emotion recognition.
How Do You Evaluate Whether the AI Actually Improves Outcomes?
The scorecard evaluates evidence through four questions covering evaluation methodology, validated clinical outcome measures (PHQ-9, GAD-7, WHO-5), engagement metrics, and independently verifiable ROI data. Ask for outcomes from AI-assisted care pathways specifically, and ask whether the vendor can demonstrate ROI with longitudinal data rather than modeled projections.
Kyan Health measures outcomes using PHQ-9 and GAD-7. Clients see up to 30% sustained engagement (10 times the traditional EAP benchmark), 90% symptom improvement, 4.9/5 satisfaction, and 8x average ROI, with fees-at-risk performance guarantees available.
Frequently Asked Questions
How do you evaluate AI mental health tools? Use a structured scoring framework covering clinical safety, data privacy, transparency, evidence, equity, governance, and IT security. The Kyan Health AI Mental Health Vendor Scorecard provides 30 questions across seven categories, scored 0 to 3 for a maximum of 90 points, built on clinical research published in World Psychiatry and regulatory requirements including the EU AI Act and GDPR.
What regulations apply to AI mental health tools in the workplace? The EU AI Act classifies workplace AI as high-risk (compliance deadline August 2026) and prohibits passive emotion recognition in employment. GDPR treats mental health data as special category data. HIPAA applies in the US. PIPEDA applies in Canada. California SB 243, effective January 2026, regulates AI companion chatbots, according to reporting by Stateline.
What are the biggest risks of AI in employee mental health? According to published research, the most significant risks include inadequate crisis detection, lack of independent clinical testing, passive emotion recognition without consent, and deploying consumer-grade AI without clinical guardrails. A 2025 Brown University study published in JMIR Mental Health found a 32% rate of endorsing harmful behaviors across 137 LLM counseling sessions.
Kyan Health is a modern EAP alternative providing global mental health support across 200+ countries. Book a demo or download the AI Mental Health Vendor Scorecard to start your vendor evaluation.
